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Abstract
Short-term exposure to ambient air pollution is linked with adverse cardiovascular effects. While 
previous research focused primarily on particulate matter-induced responses, gaseous air 
pollutants also contribute to cause short-term cardiovascular effects. Mechanisms underlying such 
effects have not been adequately described, however the immediate nature of the response suggests 
involvement of irritant neural activation and downstream autonomic dysfunction. Thus, this study 
examines the role of TRPA1, an irritant sensory receptor found in the airways, in the cardiac 
response of mice to acrolein and ozone. Conscious unrestrained wild-type C57BL/6 (WT) and 
TRPA1 knockout (KO) mice implanted with radiotelemeters were exposed once to 3 ppm acrolein, 
0.3 ppm ozone, or filtered air. Heart rate (HR) and electrocardiogram (ECG) were recorded 
continuously before, during and after exposure. Analysis of ECG morphology, incidence of 
arrhythmia and heart rate variability (HRV) were performed. Cardiac mechanical function was 
assessed using a Langendorff perfusion preparation 24 h post-exposure. Acrolein exposure 
increased HRV independent of HR, as well as incidence of arrhythmia. Acrolein also increased left 
ventricular developed pressure in WT mice at 24 h post-exposure. Ozone did not produce any 
changes in cardiac function. Neither gas produced ECG effects, changes in HRV, 
arrhythmogenesis, or mechanical function in KO mice. These data demonstrate that a single 
exposure to acrolein causes cardiac dysfunction through TRPA1 activation and autonomic 
imbalance characterized by a shift toward parasympathetic modulation. Furthermore, it is clear 
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from the lack of ozone effects that although gaseous irritants are capable of eliciting immediate 
cardiac changes, gas concentration and properties play important roles.
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1. Introduction
Ambient air pollution has been linked to adverse cardiovascular effects by numerous 
epidemiological, human and animal studies. Although most of the research over the last 
decade have focused on particulate matter (PM), recent data suggest gaseous pollutants 
likely contribute significantly to acute decrements in cardiac function and result in increased 
overall risk for cardiovascular dysfunction (Campen et al., 2014; Hazari et al., 2014; Mills et 
al., 2015; Shah et al., 2015). In fact, the 2010 American Heart Association document on PM 
and cardiovascular disease clearly states that “Although PM2.5 mass has rightfully attracted 
attention as a target for regulation and epidemiological study, more than 98% of the air 
pollutant mass in the mixture we breathe in urban settings is from gases or vapor-phase 
compounds…”, not to mention there is still relatively little data describing the effects of 
gaseous pollutants on the cardiovascular system (Brook et al., 2010). Thus, more studies are 
needed to determine the effect of individual gases and their causative pathways, particularly 
given the mechanism underlying the response will undoubtedly differ for the gas alone and 
when combined with other pollutants such as PM.
In addition to “criteria” pollutant gases like ozone (O3) for which the United States 
Environmental Protection Agency has set National Ambient Air Quality Standards 
(NAAQS), non-NAAQS hazardous air pollutants (HAPs) such as acrolein are also frequently 
present in ambient air pollution, particularly in emissions from combustion processes 
including exhaust from automobiles, emissions from coal-fired power plants, and emissions 
from industrial sites (CDC ToxProfile). Acrolein is a gaseous irritant formed during the 
combustion of petrochemical fuels such as gasoline or diesel and it is considered to pose the 
greatest relative HAP hazard for non-cancer health effects ((Haussmann, 2012). To that 
point, we previously showed that a single exposure to either O3 or acrolein causes various 
cardiovascular effects in rodents; these range from electrocardiogram changes, autonomic 
imbalance, desensitization of baroreflex, to alterations in hypoxia responsiveness (Farraj et 
al., 2012; Hazari et al., 2009b; Hazari et al., 2014; Perez et al., 2013). Moreover, many of 
these effects appear to be latent and are only evident if the body is challenged or encounters 
a subsequent trigger (Hazari et al., 2012), which would suggest the underlying mechanisms 
involve the disruption of homeostatic controls which maintain equilibrium of vital bodily 
systems under changing conditions.
Numerous biological pathways have been described that link air pollution with 
cardiovascular dysfunction. These include systemic inflammation and oxidative stress, 
vasoconstriction, enhanced coagulation/thrombosis, autonomic effects due to sensory 
receptor activation, and the direct effects of translocated particles on the myocardium (Brook 
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et al., 2010). Of these, airway sensory activation may be the most relevant when considering 
the short-term, reversible, and often latent effects of an acute ambient exposure. An 
examination of the role of airway sensory nerves in the body indicates that not only do they 
“sense” or become activated by specific gaseous pollutants but also cause internal 
homeostatic changes that may predispose to respiratory and cardiovascular dysfunction 
(Jordt and Ehrlich, 2007; Lee and Pisarri, 2001).
Gaseous air pollutants such as ozone, acrolein, and other reactive aldehydes commonly 
found in combustion-derived exhaust, stimulate sensory nerves in the airways causing 
several well-described ventilatory and pulmonary effects (Abbott-Banner et al., 2013; Büch 
et al., 2013; Jordt, 2011; McDonnell et al., 1983). A subset of these responses is known to be 
mediated by airway sensors, particularly transient receptor potential cation channels A1 
(TRPA1) and V1 (TRPV1), located on pulmonary C-fibers (Nassenstein et al., 2008; Taylor-
Clark et al., 2008). It has been suggested that these sensors may also mediate some 
cardiovascular responses as well (Hazari et al., 2011; Jones et al., 1995; Lee, 2010; Wang et 
al., 2000) and in fact, our previous studies have demonstrated that pharmacological 
inhibition of TRPA1 attenuates air pollution-induced cardiac arrhythmia produced by 
autonomic imbalance in rats (Hazari et al., 2011).
Thus, in the present study we investigated the cardiac effects of exposure to acrolein or 
ozone inhalation with WT and TRPA1 KO mice. Acrolein was chosen because it is a 
common gaseous component of urban air pollution and a known TRPA1 activator (Bautista 
et al., 2006). Only a single study has shown that ozone, albeit in solution and not inhaled, 
activates TRPA1 (Taylor-Clark and Undem, 2010), yet its irritant properties suggest that 
such a finding is not unreasonable. Regardless, although both have been traditionally 
classified as respiratory irritants, data from the last five years have clearly shown that both 
gases not only also affect the cardiovascular system but other organ systems through 
pathways which implicate a role for the intrinsic control mechanisms of the body (Bessac 
and Jordt, 2010; DeJarnett et al., 2014; Miller et al., 2015). The concentration of acrolein 
used in this study was admittedly high to serve as a proof of concept but certainly there are 
extreme conditions (e.g. structural fires), occupational settings or cigarette smoke (World 
Health Organization Concise International Chemical Assessment Document: Acrolein) in 
which the levels of acrolein exceed those used here. Irrespective of this high concentration, 
the broader aim was to not only firmly establish a role for TRPA1 in air pollution-induced 
electrical and mechanical cardiovascular dysfunction but also clarify whether inhalation of 
acrolein and ozone produce cardiovascular effects through TRPA1.
2. Materials and methods
2.1. Animals
Female C57BL/6 and TRPA1 −/− mice (22 ± 3.8 g) were used in this study (Jackson 
Laboratory - Bar Harbor, ME). Mice were initially housed five per cage and maintained on a 
12-hour light/dark cycle at approximately 22 °C and 50% relative humidity in an AAALAC–
approved facility. Food (Prolab RMH 3000; PMI Nutrition International, St. Louis, MO) and 
water were provided ad libitum. All protocols were approved by the Institutional Animal 
Care and Use Committee of the U.S. Environmental Protection Agency and are in 
Kurhanewicz et al. Page 3
Toxicol Appl Pharmacol. Author manuscript; available in PMC 2017 June 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
accordance with the National Institutes of Health Guides for the Care and Use of Laboratory 
Animals. The animals were treated humanely and with regard for alleviation of suffering. 
Background controls (B6129PF2/J mouse - Jackson Laboratory - Bar Harbor, ME) were 
used as appropriate. Only female mice were used so that we could compare the results 
obtained here to not only our previous findings but also to those of other researchers doing 
this type of work (Willis et al., 2011); a similar study including a gender comparison is 
necessary and will be performed in the near future.
2.2. Experimental groups
Wild-type and TRPA1 knockout mice were randomly assigned to one of three exposure 
groups: (1) Acrolein (Acrl); (2) Ozone (O3); or (3) filtered air (FA). There were 8–12 
animals per group.
2.3. Surgical implantation of radiotelemeters
Animals were weighed and then anesthetized using inhaled isoflurane (Isothesia, Butler 
Animal Health Supply, Dublin OH). Anesthesia was induced by spontaneous breathing of 
2.5% isoflurane in pure oxygen at a flow rate of 1 L/min and then maintained by 1.5% 
isoflurane in pure oxygen at a flow rate of 0.5 L/min; all animals received the analgesic 
Buprenorphine (0.03 mg/kg, i.p. manufacturer). Using aseptic technique, each animal was 
implanted subcutaneously with a radiotelemeter (ETA-F10, Data Sciences International, St 
Paul, MN); the transmitter was placed under the skin to the right of the midline on the dorsal 
side. The two electrode leads were then tunneled subcutaneously across the lateral dorsal 
sides; the distal portions were fixed in positions that approximated those of the lead II of a 
standard electrocardiogram (ECG). Body heat was maintained with a heating blanket both 
during and immediately after the surgery. Animals were given food and water post-surgery 
and were housed individually. All animals were allowed 7–10 days to recover from the 
surgery and reestablish circadian rhythms.
2.4. Radiotelemetry data acquisition
Radiotelemetry methodology (Data Sciences International, Inc., St. Paul, MN) was used to 
track changes in cardiovascular electrical activity by monitoring heart rate (HR), and ECG 
waveforms immediately following telemeter implantation, through exposure until 24 h post-
exposure. This methodology provided continuous monitoring and collection of physiologic 
data from individual mice to a remote receiver. Sixty-second ECG segments were recorded 
every 5 min during the pre- and post-exposure periods. ECG was recorded continuously 
during exposure (baseline and hours 1–4); HR was automatically obtained from the 
waveforms (Dataquest ART Software, version 3.01, Data Sciences International, St. Paul, 
MN, USA). All comparisons of HR, ECG parameters and HRV during exposure were made 
to the corresponding time of day during pre-/post-exposure; this was always between 8 and 
11 am.
2.5. Electrocardiogram (ECG) analysis
ECGAuto software (EMKA Technologies USA, Falls Church VA) was used to visualize 
individual ECG waveforms, analyze and quantify ECG segment durations and areas, as well 
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as identify cardiac arrhythmias as previously described (Hazari et al., 2009a). Briefly, using 
ECGAuto, P-wave, QRS complex, and T-wave were identified for individual ECG 
waveforms and compiled into a library. Analysis of all experimental ECG waveforms was 
then based on established libraries. The following parameters were determined for each 
ECG waveform: PR interval (Pstart-R), QRS complex duration (Qstart-S), ST segment 
interval (S-Tend) and QT interval (Qstart-Tend). QT interval was corrected for HR using the 
correction formula for mice QTc = QT/(RR/100)1/2 (Mitchell et al., 1998). All ECG streams 
with <10 s of identifiable cardiac cycles were excluded from ECG parameter calculations. 
Fig. 2 shows a typical ECG trace as well as examples of the types arrhythmia observed in 
this study.
2.6. HRV analysis
Heart rate variability (HRV) was calculated as the mean of the differences between 
sequential RRs for the complete set of ECG waveforms using ECGAuto. For each 1-min 
stream of ECG waveforms, mean time between successive QRS complex peaks (RR 
interval), mean HR, and mean HRV-analysis–generated time-domain measures were 
acquired. The time-domain measures included standard deviation of the time between 
normal-to-normal beats (SDNN), and root mean squared of successive differences 
(RMSSD). SDNN represents overall HRV, while RMSSD represents parasympathetic 
influence over HRV. Analysis of HRV was also conducted in the frequency domain using a 
fast-Fourier transform. For frequency domain analysis, the signal was analyzed with a 
Hamming window for segment lengths of 512 samples with 50% overlapping. The spectral 
power obtained from this transformation represents the total harmonic variability for the 
frequency range being analyzed. In this study, the spectrum was divided into low-frequency 
(LF) and high-frequency (HF) regions with frequency bands assigned as 0.15–1.5 and 1.5–5 
Hz respectively. LF is generally believed to represent a combination of sympathetic and 
parasympathetic activity, while HF indicates cardiac parasympathetic (vagal) activity (Ori et 
al., 1992). All ECG streams with <1 min of identifiable RR intervals were excluded from 
HRV analysis. Additionally thorough visual inspection was conducted to identify and 
exclude arrhythmias and artifacts (Rowan et al., 2007).
2.7. Exposure
The study protocol included two days of animal-to-chamber acclimatization prior to 
exposure. Three or four hour exposures to acrolein or ozone respectively (Exposure) started 
with 30 min of additional chamber acclimatization. All mice were moved back to their 
home-cages after the exposure (Post-exposure) and monitored for 24 h (Post-exposure 24 h
+) before necropsy. Temperature and humidity of the chambers were maintained at between 
70 and 73 °F and 47–52%, respectively, and flow rates were kept constant.
2.8. Ozone exposure
Ozone (O3) exposures took place in whole-body exposure chambers. O3 was generated by 
passing extra dry oxygen past an arcing transformer in a model V5-0 ozone generator 
(Ozone Research & Equipment Corp., Phoenix, AZ). Chamber O3 concentrations (0.3 ppm) 
were regulated and recorded by a PC based automated data system running DASYLab 
(version 9.0; Measurement Computing Corp., Norton, MA) software. Ozone concentrations 
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were monitored using continuous gas analyzers (model 49i, model 49; Thermo Fisher 
Scientific, Foxfire, MA) which fed analog signals to the control system. DASYLab then 
used a feedback loop running a proportional, integral, derivative controller to open or close 
mass flow controllers to maintain chamber O3 concentration at the desired level. Filtered air 
control exposures were simultaneously conducted with all chamber conditions maintained 
and O3 levels < 0.010 ppm.
2.9. Acrolein exposure
Acrolein exposures took place in whole-body plethysmography chambers (Model PLY3213, 
Buxco Electronics, Inc., Wilmington, NC, USA). Acrolein gas was metered from a 1000 
ppm cylinder into a glass mixing chamber where the gas was mixed and diluted with dry 
filtered air to achieve a final concentration of 3 ppm of acrolein with a total flow of 6 L/min. 
The actual chamber concentration was measured once per hour using an HP5890 gas 
chromatograph (GMI Inc., Ramsey, MN, USA) equipped with manual injection, a flame 
ionization detector and a DB-VRX capillary column.
2.10. Cardiac perfusion
The procedure for cardiac perfusion has been previously described (Tong et al., 2010). 
Briefly, 24 h after exposure, mice were anesthetized with sodium pentobarbital (80 mg/kg, 
i.p.). Heparin (100 units) was injected intravenously before removal of heart. The hearts 
were rapidly removed and placed in ice-cold Krebs-Henseleit buffer, after which the aortas 
were cannulated. Retrograde perfusion via the aorta was performed under constant pressure 
(100 cm H2O) above the heart. The non-recirculating perfusate was a Krebs-Henseleit buffer 
containing (in mmol/L) 120 NaCl, 5.9 KCl, 1.2 MgSO4, 1.75 CaCl2, 25 NaHCO3, and 11 
glucose. The buffer was aerated with 95% O2−5% CO2 and maintained at pH 7.4 and a 
temperature of 37 °C.
For assessment of contractile function, a latex balloon on the tip of a polyethylene catheter 
was inserted through the left atrium into the left ventricle. The catheter was connected to a 
pressure transducer (Argon Medical Devices, Athens, TX) at the same height as the heart. 
The pressure of the left ventricular balloon was inflated to 0–5 cm H2O. A PowerLab system 
was used to collect and process the heart rate, left ventricular developed pressure (LVDP), 
and contractility (dP/dt) data (AD Instruments, Milford, MA). All hearts were perfused for 
25 min; we then initiated 20 min of global no-flow ischemia by stopping the flow of 
oxygenated perfusion buffer, followed by 1 h of reperfusion. Onset of ischemic contracture 
was measured as the time from the start of ischemia until initial contracture (at least 5 cm 
H2O increase in left ventricular pressure). Recovery of LVDP, expressed as a percentage of 
the initial pre-ischemic LVDP, was measured at 20, 40 and 60 min of reperfusion after 20 
min of ischemia.
2.11. Statistics
All data are expressed as means ± SEM. Statistical analyses of the data were performed with 
GraphPad Prism 5 (GraphPad software, San Diego CA). A minimum power of 0.8 was used 
to determine sample size. For HR, ECG intervals and HRV, two-way analysis of variance 
(ANOVA) for repeated-measures and Bonferroni post hoc tests were used to determine 
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statistical differences. A one-way ANOVA was used to analyze arrhythmia counts. For 
Langendorff cardiac perfusion data, comparisons between groups were performed by one-
way ANOVA followed by Bonferroni post hoc test for multiple comparisons. Comparisons 
were made across all groups taking into account the multiple endpoints, exposure groups 
and time points as well as any interactions.
3. Results
3.1. Heart rate
Table 1 lists the average heart rates before, during and after exposure. The Pre-exposure 
period represents a 4 hour time-matched period one day before exposure. The Post-exposure 
period represents the 4 h directly following exposure, and the 24 h Post-exposure represents 
a 4 h time-matched period one day after exposure. All animals experienced an increase in 
HR when initially placed in the exposure chamber and all progressively decreased over the 
course of the exposure. There were no significant differences in HR within the strains among 
any of the exposure groups during any time period, however the WT animals demonstrated a 
more robust increase in HR in every exposure group compared with the KO animals. 
Exposure to ozone did produce a decrease in HR in the KO animals compared with the pre-
exposure period and compared with ozone-exposed WT animals. In addition, there were no 
behavioral differences between any of the animal groups either during or after either 
exposure.
3.2. Electrocardiogram (ECG)
Table 2 shows the ECG parameters before, during and after exposure. There were no 
significant differences in ECG interval durations between animals exposed to acrolein or 
ozone compared with filtered air during any time period. When compared to the pre-
exposure period, WT animals had no significant changes in ECG interval durations during 
the exposure period. In contrast, KO mice demonstrated slight increases in QRS and QTc 
interval lengths during acrolein, ozone, and filtered air exposure indicating that these were 
likely a physiological response of the KOs to placement in the exposure chamber rather than 
a response to the pollutant.
3.3. Heart rate variability (HRV)
Exposure to acrolein caused significant increases in all measures of HRV in WT animals, 
including the time domain measurements SDNN and RMSSD (Fig. 1A and B), as well as 
the high and low frequency domain measurements (Fig. 1C and D) when compared with 
filtered air and KO mice. There was no effect of acrolein on KO mice nor was there any 
effect of ozone exposure on either WT or KO mice.
3.4. Cardiac arrhythmias
Typical ECG and cardiac arrhythmias observed in mice exposed to acrolein and ozone are 
shown in Fig. 2. There was a significant increase in the number of arrhythmia during the 3 
hour exposure period to acrolein (27.8 ± 10.8) when compared with filtered air (2.2 ± 0.9) 
(Fig. 3). No other significant differences in arrhythmias were observed between any 
exposure groups at any time period.
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3.5. Cardiac mechanical effects
Post-exposure (pre-ischemic) and post-ischemic left ventricular pressure measurements are 
summarized in Table 3. Exposure to acrolein significantly increased LVDP 24 h post-
exposure (129.9 ± 10.3 cm H2O) compared with filtered air-exposed controls (86.4 ± 7.8 cm 
H2O) (Fig. 4). There were no other significant differences in cardiac mechanical function 
between any other groups at any other time points.
4. Discussion
The results of this study demonstrate that TRPA1 channels found on airway sensory nerves, 
which can be described as sensors for a broad array of environmental irritants, play a role in 
the cardiovascular response of mice to acrolein. The data presented here also suggests that a 
single exposure to gaseous irritant pollutants causes not only cardiac electrical disturbances, 
which are commonly observed in humans (Peters et al., 2000), but acute, nearly 
imperceptible changes in cardiac mechanical function as well; these findings corroborate not 
only our previous work (Kurhanewicz et al., 2014) but the work of others (Tong et al., 2010). 
More importantly, the current study confirms that gaseous air pollutants have effects beyond 
the respiratory system affecting not only cardiac function but also the homeostatic control of 
the cardiovascular system as indicated by changes in HRV. Although blood pressure was not 
measured in this study, our previous results (Perez et al., 2013) confirm that the effects of 
acrolein exposure likely involve subtle disruptions to intrinsic cardiovascular controls. In 
order to elucidate how gaseous air pollutants may cause this cardiac dysfunction, we 
investigated the role of TRPA1 by using high concentrations of acrolein as a putative 
positive control and lower concentrations of ozone as a more relevant and real-world 
exposure. Acrolein produced abnormal modulation of autonomic balance and an increased 
incidence of arrhythmia through TRPA1, which also mediated an increase in LVDP. In 
contrast, exposure to ozone did not appear to cause any significant effects despite the fact 
that mild cardiovascular effects of ozone at similar levels have been documented by our lab 
in the past and by others (Barath et al., 2013; Farraj et al., 2012; Farraj et al., 2015; 
Kurhanewicz et al., 2014; Wang et al., 2013; Wu et al., 2010).
Sensory receptors in the respiratory system, from the nose down to the lower lungs, respond 
to gaseous irritants and initiate visceral (i.e. autonomic) reflexive changes which impact the 
function of the cardiovascular system. While it is unlikely that inhalation of these gases 
affects the heart or vasculature by causing direct toxicity or damage, there is certainly 
enough data that suggests signals initiated in the airways can lead to altered cardiovascular 
regulation, compensatory deficits, and increased sensitivity to subsequent exposures 
(Widdicombe and Lee, 2001). For example, the prevalence of arrhythmias, although not life-
threatening in and of themselves, are increased in people exposed to smoke (Carey and 
Thevenin, 2009). Thus, these irritant gases may not be overtly deleterious but rather may 
increase the risk of an adverse response if another stressor is encountered and the body is 
unable to maintain homeostasis. We previously showed that acrolein exposure increases risk 
by desensitizing the baroreflex (Hazari et al., 2014), which maintains blood pressure, and 
therefore systemic perfusion, by altering heart rate. As such, the baroreflex, as an internal 
sensor of blood pressure, operates and exerts its effects through the sympathetic and 
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parasympathetic branches of the autonomic nervous system. Therefore any exposure-related 
changes in autonomic balance, which can be measured through HRV, might result in altered, 
and possibly impaired, regulation of the cardiovascular system. Although yet 
unsubstantiated, TRPA1 activation by acrolein may represent the initiating event for this 
baroreflex desensitization given its association with autonomic imbalance as we have shown 
here.
While the results from this study do not provide direct evidence of serious cardiac morbidity 
or premature mortality as a result of acute exposure to airway irritants, they may reflect a 
transient instability that can worsen if exposure continues over a longer period. Moreover, 
such dysregulation in individuals with pre-existing regulatory issues or disease resulting in 
poor compensatory capacity could be more seriously impacted. Performing studies in at-risk 
humans is problematic, so as a result these fundamental relationships in autonomic cardiac 
dysfunction may only be dissected in rodent models. As data examining autonomic function 
in rodents in the past had to be interpreted cautiously due to the use of anesthesia, the 
current results were produced from conscious unrestrained mice that could be monitored 
continuously during exposure, thus improving discernibility of toxicological effects relevant 
to human scenarios. Still, HRV data in rodents is not easily interpretable given that several 
dynamic factors contribute to it (Rowan et al., 2007).
Exposure to acrolein produced significant increases in SDNN, RMSSD, LF power and HF 
power in WT mice; this response was not present in acrolein-exposed TRPA1 KO animals. 
While decreased HRV is commonly accepted as an indicator of heightened cardiovascular 
risk in humans (Gold et al., 2000), increased HRV has also been linked to adverse 
cardiovascular outcomes (Stein et al., 2005). Indeed, other reports note increased HRV as an 
indicator of heightened risk. For example, increased RMSSD has been shown to be 
associated with elevated risk of air pollution-induced arrhythmia (Davoodi et al., 2010) and 
increases in HRV have been demonstrated preceding post-operative atrial fibrillation (Amar 
et al., 2003). Additionally, increases in vagal tone have been associated with adverse 
cardiovascular events in type II diabetics (Eguchi et al., 2010), and linked with increased 
mortality in heart failure patients and the elderly (de Bruyne et al., 1999; Stein et al., 2005). 
With regard to the animal models, we have consistently shown that exposure to different 
types of air pollutants such as residual oil fly ash (Carll et al., 2015; Farraj et al., 2011), 
diesel exhaust (Carll et al., 2013; Hazari et al., 2011), ozone (Farraj et al., 2012) and acrolein 
(Hazari et al., 2014) all lead to an increase in HRV in rodent models. This is not entirely 
surprising given increased HRV, and in particular RMSSD and HF, indicate parasympathetic 
modulation which is a well-characterized reflex response to airway sensory activation (Lee 
and Pisarri, 2001). Thus, it is clear the relationship between HRV and cardiac dysfunction 
cannot be overly simplified to say increased HRV is good whereas decreased HRV is bad. 
Instead, it is the imbalance of this homeostatic mechanism, regardless of direction of change, 
which likely produces the increase in risk. In fact, observation of simultaneous electrical 
disturbances in the ECG, like AV node block, along with an increase in HRV may confirm 
the underlying shift from normal function.
In our studies, increased HRV, and therefore parasympathetic modulation, was observed 
with an increased incidence of sinus node dysfunction and dysrhythmia (Fig. 2) during 
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acrolein exposure in normal animals. Increased vagal tone can cause such changes in the P-
wave to P-wave interval independent of normal breathing. This condition is known as non-
respiratory sinus arrhythmia and it differs from respiratory sinus arrhythmia (RSA) in that it 
is not associated with respiration but rather occurs when the outflow of parasympathetic tone 
predominates over sympathetic tone (Deboor et al., 2005; McMullen et al., 2012) and unlike 
RSA is grossly irregular. Furthermore, non-respiratory sinus arrhythmia or dysrhythmia 
when observed with sinus node dysfunction can indicate sick sinus syndrome (Keller and 
Lemberg, 2006), which is a group of abnormal heart rhythms that appear not only as a 
blocked sinus signal but also as random intervals of bradycardia and tachycardia. Although 
these parameters fit what we observed with acrolein, it still remains to be determined 
whether it represents a toxicological effect that leads to adverse systemic outcomes; yet it 
would not be unreasonable to suspect that such a change might predispose an individual to 
subsequent triggered responses. Increases in HRV associated with increased randomness of 
the heart rate, that is, a high degree of non-respiratory sinus arrhythmia have been found to 
be strongly associated with risk of mortality (McMullen et al., 2012; Stein, 2004).
Interpreting the frequency domain of the HRV data is a bit more challenging. The cardiac 
cycle and R-R interval variability are affected by multiple control mechanisms including 
autonomic modulation at the SA node, the dynamic regulation of the vasculature, as well as 
endocrine/paracrine, endothelial and mechanical factors. Additionally, complex control 
mechanisms including baroreflex and respiratory sinus arrhythmia can also drive changes in 
these parameters. Numerous studies have shown that the HF power component of HRV is 
strongly associated with cardio vagal activity (Billman, 2013; Chess et al., 1975; Heathers, 
2014; Piccirillo et al., 2009). In contrast, there is a growing body of evidence directly 
countering the claim that LF power is proportional to cardiac sympathetic nerve activity 
(Billman, 2013; Goldstein et al., 2011; Reyes del Paso et al., 2013). In fact, a number of 
studies suggest that LF power may better reflect other mechanisms exerting regulatory 
control over the cardiac cycle such as baroreflex activity in response to vasomotor tone 
(Goldstein et al., 2011; Moak et al., 2007; Rahman et al., 2011). Investigators have also used 
LF/HF, which was popularized in the 1980s, as a measure of sympatho-vagal balance 
(Pagani et al., 1984), however more recent analysis of this metric has cast doubt on its 
interpretation (Billman, 2013; Heathers, 2014; Reyes del Paso et al., 2013). Although the 
two branches of the autonomic nervous system may act reciprocally, they can also be co-
activated or completely uncoupled and function independently of one-another (Amar et al., 
2003; Reyes del Paso et al., 2013). Thus, theoretically the HF and LF power measurements 
may provide information relating to different physiological control mechanisms. Namely 
that HF power may be more strongly related to vagal influence while LF may provide 
information about not only parasympathetic factors but also a mix of sympathetic and other 
factors such as blood pressure control mechanisms including modulation of vasomotor tone 
(Billman, 2013; Reyes del Paso et al., 2013).
Notably, in this study exposure to ozone produced no discernable adverse cardiac effects in 
either WT or KO mice. While these results corroborate both our previous findings and those 
of others (Barath et al., 2013; Farraj et al., 2012; Farraj et al., 2015; Wang et al., 2013; Wu et 
al., 2010) they also highlight the fact that the cardiovascular response to low level or near-
ambient ozone is quite variable and requires further investigation. We assumed a role for 
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TRPA1 given the findings of Taylor-Clark and Undem (Taylor-Clark and Undem, 2006) who 
showed activation of TRPA1 on airway C-fibers by high concentrations of ozone 
(approximately 7.2 ppm) in an ex-vivo system. Therefore, the lack of discernable effects in 
this study may be due to the lower concentrations of ozone applied in our study as well as 
differences intrinsic to the in-vivo system which would certainly have changed the exposure 
profile (i.e. presence of epithelium, lining fluid, etc.). To that point, the activity level of the 
subjects also contributes to the dose of ozone received as exercise has been shown to 
increase the dose of ozone delivered to the lungs (Hatch et al., 1994). In this study, where the 
mice were primarily at rest, the effective dose of ozone delivered to the lower airways would 
be relatively low. Additionally, phenotypic differences between the subtypes of C-fibers 
being targeted by acrolein and ozone may also account for some of the differences observed 
in our responses. Acrolein is known to primarily impact the upper airways and not penetrate 
much past the larynx while ozone can reach deep into the lung. As such, C-fibers 
demonstrate phenotypic differences in their sensitivities and responses to chemical and 
mechanical stimuli based on location (Lee and Pisarri, 2001) (Coleridge and Coleridge, 
1984). Hence, differences in activation of C-fiber subtypes may account for the disparate 
responses observed.
Our study demonstrates that autonomic nervous system function can be modulated by 
TRPA1, and appears to also play a role in the acrolein-induced cardiac arrhythmia and 
mechanical changes (Table 4). Stimulation of the nasal or laryngeal mucosa with an irritant 
such as acrolein has been shown to cause a slowing of the HR in combination with an 
irregular rhythm (Kratschmer, 2001), however there are very little data demonstrating a link 
between airway irritation and cardiac dysrhythmia. TRPA1 activation increases the release 
of glutamate, a centrally-acting neurotransmitter that facilitates transmission in the nucleus 
tractus solitarius (Sun et al., 2009). Although yet unproven, it is conceivable that this 
modulation of central neurotransmission can result in autonomic modulation and altered 
cardiovascular function. Similar mechanisms have already been demonstrated in models of 
cigarette smoke irritation (Mutoh et al., 2000) as well as others (Paton and Nolan, 2000; 
Simms et al., 2006), while TRPA1’s role in modulating other “autonomic” activity (e.g. 
breathing) in the brainstem is also known (Tani et al., 2015). Another possible contributing 
mechanism is neuroinflammation from the release of neuropeptides; which not only affect 
the airways locally but can also have central neural as well as systemic effects. However, we 
do not have any data to substantiate this in our model. TRPA1 also appears to play a role in 
the increase in LVDP 24 h after exposure. We have also shown myocardial dyssynchrony 
and increased left ventricular stroke volume in C57BL/6 mice 24 h after acrolein (Thompson 
et al., 2016). Similarly, Tong et al. (Tong et al., 2010) showed a trend toward increasing 
LVDP after particulate matter exposure. It is possible that the increase in LVDP observed 
here is a compensatory response to increased stroke volume to maintain cardiac output.
In conclusion, we showed here that a single acute exposure to acrolein disrupts normal 
autonomic balance and produces arrhythmia in healthy, young mice. We previously showed 
that TRPA1 mediates increased arrhythmia through sympathetic modulation in rats exposed 
to diesel exhaust. Although this is seemingly an opposite effect to what is described here, it 
is not entirely surprising given the previous results were demonstrated in a model of 
hypertension, which can cause decreased HRV. Regardless, disruption of autonomic 
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homeostasis can increase the risk of subsequent adverse cardiovascular events as was seen 
here with the increased incidence of arrhythmia. Acute exposure to airway irritants may not 
cause overt functional effects, but rather may produce latent or subclinical effects that are 
only manifested when the host is challenged by a subsequent stressor or disease state. 
However, the likelihood of this occurring clearly depends on not only the level (i.e. 
concentration, duration, etc.) of exposure, but the characteristics of the pollutant as well. The 
underlying health of the host must also be considered because the greatest risk may be in 
subjects with eroded or impaired compensatory capacity as is seen with chronic respiratory 
and cardiovascular disease. Despite a somewhat better understanding of this mechanism, all 
of these factors must be accounted for if a proper assessment of risk is to be made.
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Fig. 1. 
Exposure to acrolein but not ozone increases all measures of heart rate variability (HRV). 
Wildtype (WT) mice experienced an increase in SDNN, RMSSD, LF/HF, LF and HF during 
exposure to acrolein. These increases in HRV were not observed in TRPA1 KO animals. 
There was no effect of ozone exposure on either the WT or KO animals. Values are mean ± 
SEM. *p < 0.05; significantly different from FA. ‡p < 0.05; significantly different from KO 
strain (n = 8–12).
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Fig. 2. 
Typical electrocardiogram and cardiac arrhythmia in mice exposed to acrolein and Ozone. 
A. Typical mouse ECG during normal sinus rhythm. B. Sino-atrial node dysfunction 
characterized by elongation of the R-R interval and loss of discernable p-waves. C. Non-
conducted p-wave, which represents a loss of conduction from the atria to the ventricles. D. 
Typical mouse ECG during normal sinus rhythm (expanded timescale) E. Dysrhythmia 
characterized by brief periods of bradycardia dispersed between periods of normal heart rate. 
All of these arrhythmia are typical of vagal dominance.
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Fig. 3. 
Exposure to acrolein increases cardiac arrhythmias in wildtype mice. WT mice experienced 
an increase in arrhythmia during exposure to acrolein. Values are total number of arrhythmia 
occurrences during the pre-exposure, exposure and post-exposure periods. There were no 
significant differences in arrhythmia counts between any of the groups during any other 
period. *p < 0.0001; significantly different from FA. ‡p < 0.0001; significantly different 
from KO strain (n = 8–12).
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Fig. 4. 
Exposure to acrolein increases left ventricular developed pressure 24 h post-exposure. WT 
animals exposed to acrolein experienced an increase in LVDP 24 h post-exposure when 
compared to FA controls. Exposure to ozone did not produce any changes in LVDP. *p < 
0.05; significantly different from FA (n = 8–12).
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Table 1
The effect of acrolein or ozone exposure on heart rate.
Filtered air Acrolein Ozone
WT
Pre-exposure 575.9 ± 19.5* 607.3 ± 34.4 563.1 ± 11.3
Exposure 617.1 ± 9.9 638.3 ± 6.6 626.6 ± 10.5
Post-exposure 546.5 ± 13.2 573.5 ± 7.1 548 ± 9.8
24 h post-exposure 525.9 ± 14.2 552.4 ± 14.7 540.3 ± 8.8
KO
Pre-exposure 570.9 ± 19.3 575 ± 16.2 573.3 ± 9.6
Exposure 587.9 ± 14.3 600.8 ± 12.6 562.2 ± 20.7‡
Post-exposure 584.8 ± 15.8 607.5 ± 9.5 594.8 ± 13.4
24 h post-exposure 552.5 ± 17 573.2 ± 15.4 571.5 ± 9.4
Values are mean (beats/min) ± SEM (n = 8–12).
*p < 0.05; significantly different from FA.
‡p < 0.05; significantly different from WT strain.
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Table 2
The effect of acrolein or ozone exposure on electrocardiogram parameters.
PR (msec)
Filtered air Acrolein Ozone
WT
Pre-exposure 35.16 ± 0.59* 32.65 ± 0.51 34.14 ± 0.74
Exposure 37.02 ± 0.4 34.33 ± 0.73 35.26 ± 0.58
Post-exposure 35.34 ± 0.54 32.82 ± 0.52 34.25 ± 0.59
KO
Pre-exposure 30.34 ± 0.65 29.35 ± 0.35 30.17 ± 0.69‡
Exposure 30.95 ± 0.77 31.36 ± 0.75‡ 31.97 ± 0.75‡
Post-exposure 32.33 ± 0.98 31.84 ± 0.75 32.75 ± 0.74
QRS (msec)
Filtered air Acrolein Ozone
WT
Pre-exposure 13.41 ± 0.52 11.9 ± 0.08 12.45 ± 0.3
Exposure 12.4 ± 0.35 11.14 ± 0.28 12.23 ± 0.18
Post-exposure 13.28 ± 0.48 11.74 ± 0.02 12.34 ± 0.28
KO
Pre-exposure 11.96 ± 0.34 12.43 ± 0.31 11.66 ± 0.25
Exposure 13.64 ± 0.56† 14.21 ± 0.58†,‡ 13.45 ± 0.5†
Post-exposure 11.78 ± 0.35 12.39 ± 0.33 11.71 ± 0.36
QTc (msec)
Filtered air Acrolein Ozone
WT
Pre-exposure 74.58 ± 3.07 65.94 ± 2.08 71.58 ± 2.69
Exposure 67.98 ± 2.14 68.1 ± 1.73 69.39 ± 1.34
Post-exposure 73.93 ± 3.93 63.36 ± 2.15 69.95 ± 2.95
KO
Pre-exposure 72.38 ± 1.18 71.81 ± 1.34 72.58 ± 3.11
Exposure 82.91 ± 3.39†,‡ 84.74 ± 4.07†,‡ 81.93 ± 4.02†,‡
Post-exposure 67.68 ± 1.76 70.18 ± 1.21 67.29 ± 2.38
Values are mean ± SEM (n = 8–12).
*p < 0.05; significantly different from FA.
†p < 0.05; significantly different from pre-exposure period.
‡p < 0.05; significantly different from WT strain.
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